The role of photochemical treatment with amotosalen and UV-A light in the prevention of transfusion-transmitted cytomegalovirus infections.

Author: ConlanMaureen, DrewW Lawrence, LjungmanPer, NicholsW Garrett, PreiksaitisJutta K, RobackJohn D

Paper Details 
Original Abstract of the Article :
Primary cytomegalovirus (CMV) infection is usually asymptomatic in immunocompetent patients but can cause serious life-threatening complications in immunocompromised CMV-seronegative patients, including patients receiving a bone marrow or peripheral blood stem cell transplant, recipients of some sol...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1016/j.tmrv.2005.08.004

データ提供:米国国立医学図書館(NLM)

The Role of Photochemical Treatment with Amotosalen and UV-A Light in the Prevention of Transfusion-Transmitted Cytomegalovirus Infections

Cytomegalovirus (CMV) infection, like a stealthy desert predator, can pose a significant threat to immunocompromised patients. This study, like a vigilant sentinel guarding a precious oasis, investigates the use of photochemical treatment (PCT) with amotosalen and UV-A light to prevent transfusion-transmitted CMV (TT-CMV) infection.

The Potential of PCT for Blood Safety

This research, like a groundbreaking innovation in a long-standing tradition, highlights the potential of PCT to improve blood safety. The authors found that PCT effectively inactivates CMV in platelet concentrates and may play a vital role in reducing the incidence of TT-CMV infection in high-risk patients.

Advancing Blood Safety Practices

This research, like a beacon of hope in a vast and challenging landscape, represents a significant step forward in advancing blood safety practices. The findings provide compelling evidence for the use of PCT as a proactive approach to preventing transfusion-transmitted infections.

Dr. Camel's Conclusion

This research, like a shimmering desert mirage, offers a promising solution to a persistent challenge in blood safety. The findings underscore the importance of continued innovation in this area, ensuring that patients receive safe and effective blood transfusions. As researchers, we must remain vigilant in our pursuit of safer and more effective treatments, just as the camel tirelessly navigates the desert in search of water and a path to survival.
Date :
  1. Date Completed 2006-04-20
  2. Date Revised 2014-11-20
Further Info :

Pubmed ID

16373187

DOI: Digital Object Identifier

10.1016/j.tmrv.2005.08.004

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.